• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risperidone augmentation of paroxetine in a case of severe, treatment-refractory obsessive-compulsive disorder without comorbid psychopathology.

作者信息

Agid O, Lerer B

出版信息

J Clin Psychiatry. 1999 Jan;60(1):55-6. doi: 10.4088/jcp.v60n0112d.

DOI:10.4088/jcp.v60n0112d
PMID:10074882
Abstract
摘要

相似文献

1
Risperidone augmentation of paroxetine in a case of severe, treatment-refractory obsessive-compulsive disorder without comorbid psychopathology.
J Clin Psychiatry. 1999 Jan;60(1):55-6. doi: 10.4088/jcp.v60n0112d.
2
A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.一项关于在血清素再摄取抑制剂难治性强迫症中添加利培酮的双盲、安慰剂对照研究。
Arch Gen Psychiatry. 2000 Aug;57(8):794-801. doi: 10.1001/archpsyc.57.8.794.
3
Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder.利培酮增强5-羟色胺再摄取抑制剂治疗难治性强迫症的疗效。
J Clin Psychiatry. 1996 Jul;57(7):303-6.
4
Antiobsessional effect of risperidone add-on treatment in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder may be dose-dependent.
Arch Gen Psychiatry. 2002 May;59(5):472; author reply 472-3. doi: 10.1001/archpsyc.59.5.472.
5
Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders.利培酮增强5-羟色胺再摄取抑制剂治疗强迫症及相关障碍的疗效
J Clin Psychiatry. 1997 Mar;58(3):119-22. doi: 10.4088/jcp.v58n0306.
6
[Selective serotonin reuptake inhibitors in treatment of compulsive symptoms within the scope of schizophrenia].[选择性5-羟色胺再摄取抑制剂在精神分裂症范围内治疗强迫症状中的应用]
Nervenarzt. 1994 Jul;65(7):478-81.
7
A case of social phobia with obsessive-compulsive symptoms improved by paroxetine in combination with risperidone.1例伴有强迫症状的社交恐惧症患者经帕罗西汀联合利培酮治疗后病情改善。
Gen Hosp Psychiatry. 2004 May-Jun;26(3):242-3. doi: 10.1016/j.genhosppsych.2003.12.002.
8
Response to fluvoxamine augmentation for obsessive and compulsive symptoms in schizophrenia.氟伏沙明增效治疗精神分裂症强迫症状的疗效
J Child Adolesc Psychopharmacol. 2002 Spring;12(1):69-70. doi: 10.1089/10445460252943597.
9
Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?共病对儿童强迫症患者帕罗西汀治疗反应的影响：在随机临床试验中使用排除标准是否有实证支持？
J Child Adolesc Psychopharmacol. 2003;13 Suppl 1:S19-29. doi: 10.1089/104454603322126313.
10
Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder.
Int Clin Psychopharmacol. 2006 May;21(3):189-91. doi: 10.1097/01.yic.0000199453.54799.cc.

引用本文的文献

1
Characterization of Behavioral Phenotypes in Heterozygous DAT Rat Based on Pedigree.基于谱系的杂合 DAT 大鼠行为表型特征分析
Biomedicines. 2023 Sep 18;11(9):2565. doi: 10.3390/biomedicines11092565.
2
Critical Review of the Use of Second-Generation Antipsychotics in Obsessive-Compulsive and Related Disorders.第二代抗精神病药在强迫症及相关障碍中的应用的批判性评价。
Drugs R D. 2018 Sep;18(3):167-189. doi: 10.1007/s40268-018-0246-8.
3
Neuroimaging in anxiety disorders.焦虑症的神经影像学
J Neural Transm (Vienna). 2009 Jun;116(6):703-16. doi: 10.1007/s00702-008-0077-9. Epub 2008 Jun 21.
4
The genetic studies of obsessive-compulsive disorder and its future directions.强迫症的遗传学研究及其未来方向。
Yonsei Med J. 2006 Aug 31;47(4):443-54. doi: 10.3349/ymj.2006.47.4.443.
5
Dopamine transporter density of basal ganglia assessed with [123I]IPT SPET in obsessive-compulsive disorder.用[123I]IPT单光子发射计算机断层扫描评估强迫症患者基底神经节的多巴胺转运体密度。
Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):1637-43. doi: 10.1007/s00259-003-1245-7. Epub 2003 Sep 25.